The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

Despite competitive pressures in the obesity market, long-term investors may stay invested in NVO stock due to strong demand ...

FRANKFURT, Germany (AP) — Pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday ...

Unlike the Get Better campaign — which was built throughout last year — Seeking launched with a full body of creative work, according to its chief corporate brand officer Lina Polimeni.

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Kenny “Babyface” Edmonds moved his mom to Vegas more than 30 years ago. He followed, and headlines Pearl at the Palms this ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

The histories of Ireland and the U.S. are woven together into one tightly knit fabric laced with the green of the Emerald ...